Vaccine envy: Why can t Canada make COVID-19 doses at home? cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Innovation Minister François-Philippe Champagne says everyone wins with Canada s new plan to ramp up vaccine manufacturing capacity at home.
The federal government will spend $415 million on the partnership with the private company Sanofi Pasteur Ltd, Ontario s government will contribute $55 million to the project, and Sanofi will pitch in $455 million, as well as an extra $79 million a year to fund Canadian research and development.
The facility will primarily manufacture influenza vaccines, but have the ability to pivot to vaccines for coronaviruses and other diseases in the case of another pandemic. It won t be up and running until 2027.
Champagne spoke to